

Liu Liang

About me
Loudi Central Hospital, Oncology Department, attending physician, has been engaged in clinical work in the field of oncology for many years, and has rich clinical experience in the diagnosis and treatment of oncologic diseases.
Proficient in diseases
Specializes in common diseases such as lung cancer, liver cancer, stomach cancer, breast cancer, colon cancer, and lymphoma.

Voices

Can prostate cancer patients eat eggs?
Patients with prostate conditions can eat eggs, as eggs are a high-protein food. Since cancer is a consumptive disease, it is important for patients to maintain a balanced diet, including meat, protein, vegetables, and fruits to ensure nutritional balance. Some cancer patients, particularly those in advanced stages who have poor appetite, may develop hypoalbuminemia due to inadequate nutrition. Such patients can benefit from consuming more eggs or protein supplements like protein powder to increase their protein intake. Patients with prostate cancer can eat eggs.

Can prostate cancer be cured?
Prostate cancer, whether it can be cured or not, depends on the specific analysis of the patient with prostate cancer. If it is an early-stage patient, meaning there is no metastasis to distant organs, and it is assessed that radical surgery or radical radiotherapy can be performed, then these early-stage prostate cancer patients still have the hope of being cured through these treatment methods. However, for patients with advanced prostate cancer, such as those who are diagnosed with multiple bone metastases at the onset—a very common clinical occurrence, prostate cancer combined with bone metastasis is very common—these advanced-stage prostate cancer patients cannot be cured through treatment. The purpose of treatment is to alleviate the patient's pain and extend the patient's survival, but these advanced-stage patients cannot be cured.

Can ovarian cancer be detected by transvaginal ultrasound?
Ovarian cancer can generally be detected through a transvaginal ultrasound. During this procedure, we can find cystic or cystic-solid, or a solid mass in the ovaries. If a blood test for tumor markers shows a significant increase in CA125, especially in combination with a large amount of ascites, we must strongly suspect ovarian cancer. In such cases, patients should undergo a tumor biopsy. By taking a biopsy and confirming it pathologically, we can definitively diagnose ovarian cancer. Therefore, most ovarian cancer patients can indeed be detected through a transvaginal ultrasound.

How is Hodgkin's lymphoma treated?
The treatment of Hodgkin's lymphoma is based on various factors including the stage of the disease as well as the general condition of the patient, among other comprehensive considerations. For patients with early stage Hodgkin's lymphoma, commonly referred to as localized Hodgkin's lymphoma, the treatment principle is a combination of chemotherapy and radiotherapy. A rational comprehensive treatment can achieve a five-year survival rate of 80% to 90%. For advanced-stage patients, such as those with stage IV Hodgkin's lymphoma, the treatment primarily consists of systemic chemotherapy. Therefore, the choice of a specific treatment plan must also consider a variety of factors based on the patient's overall condition.

Is chemotherapy effective after the recurrence of ovarian cancer?
After the recurrence of ovarian cancer, most patients can still benefit from chemotherapy again, as ovarian cancer itself is relatively sensitive to chemotherapy compared to other types of malignant tumors. If the recurrence occurs more than six months after the initial treatment, the same chemotherapy drugs used initially can still be chosen. However, if the recurrence happens within six months, the chemotherapy plan should include different drugs that were not used previously.

How is ovarian cancer diagnosed?
Ovarian cancer is discovered through transvaginal ultrasound of the adnexa uteri revealing ovarian tumors, or through imaging studies such as abdominal CT scans or MRIs showing ovarian tumors, combined with tumor markers, particularly the ovarian epithelial cancer tumor marker CA125, which will be significantly elevated. Generally, with these findings, ovarian cancer can typically be clinically diagnosed. Confirmation, however, requires pathological diagnosis, which involves obtaining a biopsy of the tumor. This can be done through a puncture biopsy or through pathological examination after surgical excision to confirm ovarian cancer. Additionally, some patients with ovarian cancer present with substantial ascites at the time of discovery. If cancer cells are found in the abdominal fluid, combined with a significant increase in CA125 and imaging studies showing ovarian tumors, ovarian cancer can also be diagnosed.

Is prostate cancer prone to metastasis?
Prostate cancer most commonly metastasizes to bones, with multiple bone metastases frequently observed clinically. In fact, the majority of prostate cancer patients already have multiple bone metastases by the time they are diagnosed. Therefore, bone is the most common distant organ to which prostate cancer spreads. Other distant organ metastases, such as to the lungs and liver, are less common, unless in very advanced stages of the disease. Additionally, prostate cancer commonly invades locally, spreading to nearby pelvic structures and tissues, such as the bladder and rectum, which is a common form of local invasion and spread.

Causes of Malignant Lymphoma
The causes of malignant lymphoma are the result of multiple factors. First, it is associated with infections by bacteria or viruses, such as the well-documented chronic infection with Helicobacter pylori, which is closely related to the occurrence of lymphoma associated with the gastric mucosa. Second, immunodeficiency conditions, like in AIDS patients or those who have been taking immunosuppressive drugs for a long period, have a higher likelihood of developing malignant lymphoma compared to the general population. Third, chemical or physical factors, such as environmental carcinogens and electromagnetic radiation, can also lead to malignant lymphoma. Other factors, such as long-term use of certain drugs like phenytoin or pseudoephedrine, and a genetic predisposition, can also be causes of malignant lymphoma.

How is prostate cancer formed?
The causes of prostate cancer are not yet very clear. According to relevant data analysis, the occurrence of prostate cancer may be related to prostate gonorrhea, infections with viruses or chlamydia, as well as the intensity of sexual activity and the impact of hormones. On the other hand, a high-fat diet and some occupational factors are also somewhat related to the disease. Therefore, the formation of prostate cancer is the result of multifactorial influences including environmental and genetic factors, personal lifestyle habits, and dietary habits, all of which are significantly interconnected.

Can prostate cancer be cured?
Early-stage prostate cancer patients can achieve a cure through radical surgery or radical radiotherapy and other treatment methods. Therefore, whether prostate cancer can be cured is related to the stage of the patient's condition. Early-stage prostate cancer patients can be cured through radical surgery or radical radiotherapy. If the cancer is diagnosed at a late stage, with extensive pelvic metastasis or multiple bone metastases, treatment for these late-stage prostate cancer patients primarily revolves around endocrine therapy. Most patients respond well to endocrine treatment; however, for these late-stage prostate cancer patients, the treatment aims to alleviate symptoms and extend survival. Through these treatments, a cure is not achievable.